Atemonate and Imuteran: novel Russian monoclonal antibody-based therapeutic agents. [electronic resource]
- Biotechnology journal Jul 2007
- 863-70 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1860-7314
10.1002/biot.200600254 doi
Antibodies, Monoclonal--therapeutic use Antineoplastic Agents--therapeutic use Clinical Trials as Topic--trends Humans Immunotherapy--trends Neoplasms--drug therapy Russia